Have a personal or library account? Click to login
Ocular Involvement in Children with Beta-Thalassemia Major Cover

Ocular Involvement in Children with Beta-Thalassemia Major

Open Access
|Oct 2024

References

  1. Vichinsky EP. Changing patterns of thalassemia woridwide. In: Ann N Y Acad Sci. 1054.; 2005:18-24.
  2. Taher AT, Saliba AN. Iron overload in thalassemia: Different organs at different rates. Hematology. 2017; 2017(1):265-271.
  3. Taher A, Bashshur Z, Shamseddeen WA, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142(4):704-705.
  4. Thalassaemia International Federation. Guidelines for the Management of Transfusion Dependent Thalassemia (TDT); 2014.
  5. Thuangtong A, Wiriyaudomchart S, Rungsiri K. Incidence of ocular toxicity from iron chelating agents at Siriraj Hospital. Siriraj Med J. 2020; 72(3):209-213.
  6. Gartaganis S, Ismiridis K, Papageorgiou O, et al. Ocular abnormalities in patients with β thalassemia. Am J Ophthalmol. 1989; 108(6):699-703.
  7. Wong RW, Richa DC, Hahn P, et al. Iron toxicity as a potential factor in AMD. Retina. 2007; 27(8):997-1003.
  8. Merchant RH, Punde H, Thacker N, et al. Ophthalmic Evaluation in Beta-Thalassemia. Indian J Pediatr. 2017;84(7):509-514.
  9. Jafari R, Heydarian S, Karami H, et al. Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol. 2015;63(9):710-715.
  10. Taneja R, Malik P, Sharma M, et al. Multiple transfused thalassemia major: Ocular manifestations in a hospital-based population. Indian J Ophthalmol. 2010; 58(2): 125-130.
  11. Gosai D, Mehariya K, Gosai J. Study of ocular manifestations in children of thalassemia. Int J Res Med Sci. 2014; 2(2):695-698.
  12. Haghpanah S, Zekavat OR, Bordbar M, et al. Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran. BMC Ophthalmol. 2020; 20(1):376.
  13. Loh A, Hadziahmetovic M, Dunaief JL. Iron homeostasis and eye disease. Biochim Biophys Acta – Gen Subj. 2009; 1790(7):637-649.
  14. Wood JC. Diagnosis and management of transfusion iron overload: The role of imaging. Am J Hematol. 82.; 2007:11321135.
  15. Susanah S, Idjradinata PS, Sari NM, et al. Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia. Sadikot R, ed. Biomed Res Int. 2020; 2020:8185016.
DOI: https://doi.org/10.2478/amb-2024-0048 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 19 - 23
Published on: Oct 3, 2024
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 B. Lubis, S. M. Lubis, B. D. Sulistyowati, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.